Literature DB >> 21273267

Compound heterozygosity for KLF1 mutations associated with remarkable increase of fetal hemoglobin and red cell protoporphyrin.

Stefania Satta1, Lucia Perseu, Paolo Moi, Isadora Asunis, Annalisa Cabriolu, Liliana Maccioni, Franca Rosa Demartis, Laura Manunza, Antonio Cao, Renzo Galanello.   

Abstract

The persistence of high fetal hemoglobin level in adults may ameliorate the clinical phenotype of beta-thalassemia and sickle cell anemia. Several genetic variants responsible for hereditary persistence of fetal hemoglobin, linked and not linked to the beta globin gene cluster, have been identified in patients and in normal individuals. Monoallelic loss of KLF1, a gene with a key role in erythropoiesis, has been recently reported to be responsible for persistence of high levels of fetal hemoglobin. In a Sardinian family, high levels of HbF (22.1-30.9%) were present only in compound heterozygotes for the S270X nonsense and K332Q missense mutations, while the isolated S270X nonsense (haploinsufficiency) or K332Q missense mutation were associated with normal HbF levels (<1.5%). Functionally, the K332Q Klf1 mutation impairs binding to the BCl11A gene and activation of the γ- and β-globin promoters. Moreover, we report for the first time the association of KLF1 mutations with very high levels of zinc protoporphyrin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21273267      PMCID: PMC3084925          DOI: 10.3324/haematol.2010.037333

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  15 in total

1.  Regulation of the human HBA genes by KLF4 in erythroid cell lines.

Authors:  M Giuseppina Marini; Loredana Porcu; Isadora Asunis; M Giuseppina Loi; M Serafina Ristaldi; Susanna Porcu; Tohru Ikuta; Antonio Cao; Paolo Moi
Journal:  Br J Haematol       Date:  2010-03-15       Impact factor: 6.998

2.  Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A.

Authors:  Vijay G Sankaran; Tobias F Menne; Jian Xu; Thomas E Akie; Guillaume Lettre; Ben Van Handel; Hanna K A Mikkola; Joel N Hirschhorn; Alan B Cantor; Stuart H Orkin
Journal:  Science       Date:  2008-12-04       Impact factor: 47.728

3.  Cholelithiasis and Gilbert's syndrome in homozygous beta-thalassaemia.

Authors:  R Galanello; S Piras; S Barella; G B Leoni; M D Cipollina; L Perseu; A Cao
Journal:  Br J Haematol       Date:  2001-12       Impact factor: 6.998

4.  The erythroid phenotype of EKLF-null mice: defects in hemoglobin metabolism and membrane stability.

Authors:  Roy Drissen; Marieke von Lindern; Andrea Kolbus; Siska Driegen; Peter Steinlein; Hartmut Beug; Frank Grosveld; Sjaak Philipsen
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

5.  DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.

Authors:  Guillaume Lettre; Vijay G Sankaran; Marcos André C Bezerra; Aderson S Araújo; Manuela Uda; Serena Sanna; Antonio Cao; David Schlessinger; Fernando F Costa; Joel N Hirschhorn; Stuart H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-30       Impact factor: 11.205

6.  Amelioration of Sardinian beta0 thalassemia by genetic modifiers.

Authors:  Renzo Galanello; Serena Sanna; Lucia Perseu; Maria Carla Sollaino; Stefania Satta; Maria Eliana Lai; Susanna Barella; Manuela Uda; Gianluca Usala; Goncalo R Abecasis; Antonio Cao
Journal:  Blood       Date:  2009-08-20       Impact factor: 22.113

7.  Mutations in EKLF/KLF1 form the molecular basis of the rare blood group In(Lu) phenotype.

Authors:  Belinda K Singleton; Nicholas M Burton; Carole Green; R Leo Brady; David J Anstee
Journal:  Blood       Date:  2008-05-16       Impact factor: 22.113

8.  Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia.

Authors:  Manuela Uda; Renzo Galanello; Serena Sanna; Guillaume Lettre; Vijay G Sankaran; Weimin Chen; Gianluca Usala; Fabio Busonero; Andrea Maschio; Giuseppe Albai; Maria Grazia Piras; Natascia Sestu; Sandra Lai; Mariano Dei; Antonella Mulas; Laura Crisponi; Silvia Naitza; Isadora Asunis; Manila Deiana; Ramaiah Nagaraja; Lucia Perseu; Stefania Satta; Maria Dolores Cipollina; Carla Sollaino; Paolo Moi; Joel N Hirschhorn; Stuart H Orkin; Gonçalo R Abecasis; David Schlessinger; Antonio Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-01       Impact factor: 11.205

9.  A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15.

Authors:  Stephan Menzel; Chad Garner; Ivo Gut; Fumihiko Matsuda; Masao Yamaguchi; Simon Heath; Mario Foglio; Diana Zelenika; Anne Boland; Helen Rooks; Steve Best; Tim D Spector; Martin Farrall; Mark Lathrop; Swee Lay Thein
Journal:  Nat Genet       Date:  2007-09-02       Impact factor: 38.330

10.  Alpha-thalassemia carrier identification by DNA analysis in the screening for thalassemia.

Authors:  R Galanello; C Sollaino; E Paglietti; S Barella; C Perra; I Doneddu; M G Pirroni; L Maccioni; A Cao
Journal:  Am J Hematol       Date:  1998-12       Impact factor: 10.047

View more
  28 in total

1.  Using the hemoglobin switch for the treatment of sickle cell disease.

Authors:  Jan Cools
Journal:  Haematologica       Date:  2012-02       Impact factor: 9.941

2.  Erythroid phenotypes associated with KLF1 mutations.

Authors:  Joseph Borg; George P Patrinos; Alex E Felice; Sjaak Philipsen
Journal:  Haematologica       Date:  2011-05       Impact factor: 9.941

3.  The switch from fetal to adult hemoglobin.

Authors:  Vijay G Sankaran; Stuart H Orkin
Journal:  Cold Spring Harb Perspect Med       Date:  2013-01-01       Impact factor: 6.915

Review 4.  Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders.

Authors:  Daniel E Bauer; Sophia C Kamran; Stuart H Orkin
Journal:  Blood       Date:  2012-08-17       Impact factor: 22.113

Review 5.  β-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies.

Authors:  Stefano Rivella
Journal:  Haematologica       Date:  2015-04       Impact factor: 9.941

6.  Compound heterozygosity for KLF1 mutations is associated with microcytic hypochromic anemia and increased fetal hemoglobin.

Authors:  Jiwei Huang; Xinhua Zhang; Dun Liu; Xiaofeng Wei; Xuan Shang; Fu Xiong; Lihua Yu; Xiaolin Yin; Xiangmin Xu
Journal:  Eur J Hum Genet       Date:  2015-01-14       Impact factor: 4.246

7.  Transcription factors KLF1 and KLF2 positively regulate embryonic and fetal beta-globin genes through direct promoter binding.

Authors:  Yousef N Alhashem; Divya S Vinjamur; Mohua Basu; Ursula Klingmüller; Karin M L Gaensler; Joyce A Lloyd
Journal:  J Biol Chem       Date:  2011-05-24       Impact factor: 5.157

Review 8.  The multifunctional role of EKLF/KLF1 during erythropoiesis.

Authors:  Miroslawa Siatecka; James J Bieker
Journal:  Blood       Date:  2011-05-25       Impact factor: 22.113

9.  Original Research: Stable expression of miR-34a mediates fetal hemoglobin induction in K562 cells.

Authors:  Christina M Ward; Biaoru Li; Betty S Pace
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-02

Review 10.  The prevention of thalassemia.

Authors:  Antonio Cao; Yuet Wai Kan
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.